Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Won't last Adcom soon.
Oct. Is harvesting season November vote more states legalize. Pay up/loans, buy real estate. Boom.$$$$GLTA
https://finance.yahoo.com/news/analysts-bet-trevena-trvn-pain-003603980.html
Analysts Bet Trevena’s (TRVN) Pain Management Drug Will Get FDA Approval
It will, possible .0004
Yup
Ha ha ha, Foolish ppl. More offerings come with more delution. Best short I ever had.
Alright, let's go for a grandspankin new
52wk low
Well positioned to rob you of everything you have. And if you stay here you deserve it. You've been warned repeatedly...
Many have been Destroyed by this Theif.
GLTA
TRVN. Will be 2.00 before you know it .GL
Been loading with Adcom. In my sights. GL
Thanks again God bless
New here and to the stock, Other large note holders tia
Got to love this $tuff
Yeah but will you take that gamble every time
You are good to go at .0007 Boss gl
Thanks for the welcome in the heads up folks take care gl
Just getting up to speed on the info
Out of the sub into the green. Consolidate or continue, thoughts.
New to the board also.
It's going to break out like a wild horse
Loading up now
Working on a new low, Watch out..
.85 coming
It ain't dead yet!
Oliceridine NDA remains on track for a November 2, 2018 FDA decision –
– First license agreements for ex-US development and commercialization of oliceridine add potential revenue streams –
– Early pipeline continues to advance –
CHESTERBROOK, Pa., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (TRVN) today announced financial results for the quarter ended June 30, 2018 and provided an update on its pipeline of differentiated new chemical entities, including its lead asset, oliceridine, currently under review by the U.S. Food and Drug Administration (FDA) for potential approval this year.
This will be@ $10.00 before Thanksgiving.
$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
Ppl loading up BIG!!!$$$$$
Where's the*#p~PERMITS!?!?!?%=\
New here and been on the fence about the company short list updates? Aug.
Wowsers $5 buyout offer
That will be my entry point GLTY.
Here come the trips
Ty will hold and add on dips
Certainly something bad for this to be down for this long. Extreme Caution here
Yup
Manipulation abounds when you see eight one share trades jeez.
What are u waiting for. Talk is cheap
Oh yeah, Bankrupt shell company will be replaced with another Snakeoil CEO.
Just a stock selling company with MM's from Novartis playing everyone. So keep buying this trash so you can go bankrupt with this worthless scam..glta
Things never go as planned.
Wow deserted board